Carla M Yuede Selected Research

Biomarkers (Surrogate Marker)

1/2021

Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carla M Yuede Research Topics

Disease

14	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 12/2008
3	Tauopathies 11/2023 - 01/2023
2	Amyloid Plaque 01/2023 - 12/2009
1	Mucopolysaccharidosis III (Sanfilippo Syndrome) 04/2024
1	Neurodevelopmental Disorders 01/2024
1	Autistic Disorder (Autism) 10/2023
1	Intellectual Disability (Idiocy) 10/2023
1	Nervous System Diseases (Neurological Disorders) 10/2023
1	Fountain syndrome 10/2023
1	Chemotherapy-Related Cognitive Impairment 09/2023
1	Cognitive Dysfunction 09/2023
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2023
1	Synucleinopathies 01/2023
1	Atrophy 01/2023
1	Prodromal Symptoms 10/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Dementia (Dementias) 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Psychotic Disorders (Schizoaffective Disorder) 01/2021
1	Frontotemporal Dementia (Semantic Dementia) 01/2021
1	Demyelinating Diseases (Demyelinating Disease) 03/2015
1	Mucolipidosis III Gamma 01/2014
1	Gliosis 01/2014
1	Mucolipidoses (Sialidosis) 01/2014
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 07/2013

Drug/Important Bio-Agent (IBA)

5	Amyloid (Amyloid Fibrils)IBA 04/2024 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2021
3	Amyloid beta-PeptidesIBA 01/2022 - 12/2009
2	Apolipoprotein E3IBA 12/2023 - 11/2023
2	Apolipoproteins E (ApoE)IBA 11/2023 - 10/2022
2	Peptides (Polypeptides)IBA 01/2021 - 01/2016
1	Cell Surface ReceptorsIBA 04/2024
1	CholesterolIBA 11/2023
1	ApolipoproteinsIBA 11/2023
1	Apolipoprotein E4IBA 11/2023
1	Deubiquitinating EnzymesIBA 10/2023
1	UbiquitinIBA 10/2023
1	InterferonsIBA 01/2023
1	AerosolsIBA 01/2023
1	alpha-SynucleinIBA 01/2023
1	Complement System Proteins (Complement)IBA 01/2022
1	Aquaporin 4IBA 01/2022
1	Aquaporins (Water Channels)IBA 01/2022
1	ProgranulinsIBA 01/2021
1	pimavanserinIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	mouse presenilin 1IBA 11/2020
1	Escitalopram FDA Link 11/2020
1	LigandsIBA 01/2020
1	CuprizoneIBA 03/2015
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 03/2015
1	mutalipocin IIIBA 01/2014
1	Diazepam (Valium)FDA LinkGeneric 07/2013
1	Phencyclidine (Angel Dust)IBA 07/2013
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 12/2009
1	Donepezil (Aricept)FDA LinkGeneric 12/2009
1	thioflavin TIBA 09/2009
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2008
1	Memantine (Namenda)FDA Link 12/2008

Therapy/Procedure

1	Enzyme Replacement Therapy 04/2024
1	Catheters 12/2023
1	Drug Therapy (Chemotherapy) 09/2023
1	Radiotherapy 09/2023